The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population-Reference-Cited by-同舟云学术

The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population

Published:2019-10-25 Issue:2 Volume:20 Page:277-284
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Bader Loulia,Mahfouz Ahmad^ORCID,Kasem Mohammed,Mohammed Shaban,Alsaadi Sumayya,Abdelsamad Osama,Elenani Rasha,Soaly Ezeldin,Elzouki Abdelnasser,Rizk Nasser^ORCID,Khalifa Sherief,Shahin Mohamed H.,Cavallari Larisa H.,Mraiche Fatima,Elewa Hazem^ORCID

Funder

Qatar University

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-019-0116-y.pdf

Reference36 articles.

1. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e44S–e88S.

2. Pengo V, Pegoraro C, Cucchini U, Iliceto S. Worldwide management of oral anticoagulant therapy: the ISAM study. J Thromb Thrombolysis. 2006;21:73–7.

3. Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128:1300–5. e2.

4. Gong X, Gutala R, Jaiswal AK. Quinone oxidoreductases and vitamin K metabolism. Vitam Horm. 2008;78:85–101.

5. Oldenburg J, Marinova M, Muller-Reible C, Watzka M. The vitamin K cycle. Vitam Horm. 2008;78:35–62.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS;Bioanalysis;2024-08-14

2. QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies;Clinical and Translational Science;2024-05-31

3. Interethnic differences in drug response: projected impact of genetic variations in the Saudi population;Pharmacogenomics;2023-08

4. Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population;Pharmacological Reports;2023-04-11

5. Developing Chinese race-specific warfarin dose prediction algorithms;International Journal of Clinical Pharmacy;2023-03-29